This assumption was based on earlier studies demonstrating that cutaneous melanoma is associated with multiple neoantigen-specific CD4+ and CD8+ T cells, presumably as the result of a high mutational burden in melanoma cells (20, 21). This evidence concerns the gene CD4 and cutaneous melanoma.